Body Mass Index and the Risk of Progression of Chronic Kidney Disease

被引:23
作者
Khedr, Abdelrahman [1 ,2 ]
Khedr, Essam [2 ]
House, Andrew A. [1 ]
机构
[1] Univ Western Ontario, Div Nephrol & Internal Med, London, ON N6A 5A5, Canada
[2] Ain Shams Univ, Div Nephrol & Internal Med, Cairo, Egypt
关键词
GLOMERULAR-FILTRATION-RATE; STAGE RENAL-DISEASE; DIABETIC-NEPHROPATHY; OBESITY; PROTEINURIA; CREATININE;
D O I
10.1053/j.jrn.2010.12.001
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Objective: To examine the independent relationship between obesity, as estimated by body mass index (BMI), and progression of chronic kidney disease. We hypothesized that BMI would be associated with decline in estimated glomerular filtration rate (eGFR), independent of diabetes mellitus, hypertension, and other risk factors for progression of chronic kidney disease. Design: A retrospective cohort study was carried out. Setting: The study was carried out at Nephrology ambulatory clinics of the London Health Sciences Centre, Canada. Patients: The study included incident and prevalent patients with eGFR <60 mL/min/1.73 m(2). Eligible patients were observed between the calendar years 2005 and 2007. Subjects were excluded on the basis of <12 months of follow-up, age <18 years, or past kidney transplantation. Intervention: Least-squares regression was used to estimate change of eGFR over time. Baseline clinical and demographic factors, including BMI and diabetes, were examined in univariate and multivariate analyses. Main Outcome Measure: Change in eGFR over time was assessed in this study. Results: A total of 214 subjects were observed for a mean of 4.48 +/- 1.84 years. In univariate analysis, BMI was not statistically associated with eGFR change as either a continuous or a categorical variable. Using a BMI cut-off of 30 kg/m(2), no statistical difference in slope of eGFR was found, with a decline of 2.2 mL/min/1.73 m(2) per year in the non-obese group, and 2.69 mL/min/1.73 m(2) per year in the obese group (P=.13). Multivariate analysis demonstrated high baseline eGFR, proteinuria, and diabetic nephropathy to be associated with a faster decline in eGFR. Use of renin-angiotensin-aldosterone blockade was associated with an improved slope of eGFR over time. Conclusion: Our results do not support the hypothesis that obesity is independently associated with a decline in kidney function. (C) 2011 by the National Kidney Foundation, Inc. All rights reserved.
引用
收藏
页码:455 / 461
页数:7
相关论文
共 18 条
[1]   Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy [J].
Atkins, RC ;
Briganti, EM ;
Lewis, JB ;
Hunsicker, LG ;
Braden, G ;
de Crespigny, PJC ;
DeFerrari, G ;
Drury, P ;
Locatelli, F ;
Wiegmann, TB ;
Lewis, EJ .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 45 (02) :281-287
[2]   Glomerular hemodynamics in severe obesity [J].
Chagnac, A ;
Weinstein, T ;
Korzets, A ;
Ramadan, E ;
Hirsch, J ;
Gafter, U .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2000, 278 (05) :F817-F822
[3]   Central obesity, incident microalbuminuria, and change in creatinine clearance in the epidemiology of diabetes interventions and complications study [J].
de Boer, Ian H. ;
Sibley, Shalamar D. ;
Kestenbaum, Bryan ;
Sampson, Joshua N. ;
Young, Bessie ;
Cleary, Patricia A. ;
Steffes, Michael W. ;
Weiss, Noel S. ;
Brunzell, John D. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 18 (01) :235-243
[4]   Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: Lessons from RENAAL [J].
de Zeeuw, D ;
Remuzzi, G ;
Parving, HH ;
Keane, WF ;
Zhang, ZX ;
Shahinfar, S ;
Snapinn, S ;
Cooper, MF ;
Mitch, WE ;
Brenner, BM .
KIDNEY INTERNATIONAL, 2004, 65 (06) :2309-2320
[5]   Obesity and risk for chronic renal failure [J].
Ejerblad, Elisabeth ;
Fored, C. Michael ;
Lindblad, Per ;
Fryzek, Jon ;
McLaughlin, Joseph K. ;
Nyren, Olof .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (06) :1695-1702
[6]   Predictors of new-onset kidney disease in a community-based population [J].
Fox, CS ;
Larson, MG ;
Leip, EP ;
Culleton, B ;
Wilson, PWF ;
Levy, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (07) :844-850
[7]  
Goeree R, 1995, CLIN INVEST MED, V18, P455
[8]   Is obesity a major cause of chronic kidney disease? [J].
Hall, JE ;
Henegar, JR ;
Dwyer, TM ;
Liu, JK ;
da Silva, AA ;
Kuo, JJ ;
Tallam, L .
ADVANCES IN RENAL REPLACEMENT THERAPY, 2004, 11 (01) :41-54
[9]   Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002 [J].
Hedley, AA ;
Ogden, CL ;
Johnson, CL ;
Carroll, MD ;
Curtin, LR ;
Flegal, KM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (23) :2847-2850
[10]  
Henegar JR, 2001, J AM SOC NEPHROL, V12, P1211, DOI 10.1681/ASN.V1261211